Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous disease

Abstract Chronic granulomatous disease (CGD) is a severe inborn error of immunity caused by NADPH oxidase defects. Here, we develop CRISPR/Cas9-based gene editing strategies for correction of variants in the CYBA and CYBB genes causing CGD. For X-linked CGD, we also develop a near-universal gene edi...

Full description

Saved in:
Bibliographic Details
Main Authors: Jonas Holst Wolff, Thomas Wisbech Skov, Didde Haslund, Sofie Rahbek Dorset, Anne Louise S. Revenfeld, Clotilde Aussel, Sofie E. Jørgensen, Mette Holm, Martin K. Thomsen, Sandra Ammann, Toni Cathomen, Trine H. Mogensen, Bjarne Kuno Møller, Rasmus O. Bak, Jacob Giehm Mikkelsen
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-025-62738-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849764234510991360
author Jonas Holst Wolff
Thomas Wisbech Skov
Didde Haslund
Sofie Rahbek Dorset
Anne Louise S. Revenfeld
Clotilde Aussel
Sofie E. Jørgensen
Mette Holm
Martin K. Thomsen
Sandra Ammann
Toni Cathomen
Trine H. Mogensen
Bjarne Kuno Møller
Rasmus O. Bak
Jacob Giehm Mikkelsen
author_facet Jonas Holst Wolff
Thomas Wisbech Skov
Didde Haslund
Sofie Rahbek Dorset
Anne Louise S. Revenfeld
Clotilde Aussel
Sofie E. Jørgensen
Mette Holm
Martin K. Thomsen
Sandra Ammann
Toni Cathomen
Trine H. Mogensen
Bjarne Kuno Møller
Rasmus O. Bak
Jacob Giehm Mikkelsen
author_sort Jonas Holst Wolff
collection DOAJ
description Abstract Chronic granulomatous disease (CGD) is a severe inborn error of immunity caused by NADPH oxidase defects. Here, we develop CRISPR/Cas9-based gene editing strategies for correction of variants in the CYBA and CYBB genes causing CGD. For X-linked CGD, we also develop a near-universal gene editing strategy by targeted integration of a truncated CYBB cDNA in CD34+ hematopoietic stem and progenitor cells (HSPCs). Throughout, off-target editing and chromosomal translocations are evident, which negatively impact the ability of gene-edited HSPCs to engraft in immunodeficient mice. However, by employing a high-fidelity Cas9 to minimize off-target editing, we demonstrate restoration of the multilineage engraftment potential of gene-edited HSPCs. Moreover, to further improve safety, we develop a D10A Cas9n editing approach with no detectable off-target activity or chromosomal translocations. Collectively, through risk assessments of different gene editing approaches, we present a D10A Cas9n-based strategy with improved safety, offering a potentially curative treatment for CGD patients.
format Article
id doaj-art-d2ec5e307af34c8fae6f46c031c304b9
institution DOAJ
issn 2041-1723
language English
publishDate 2025-08-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj-art-d2ec5e307af34c8fae6f46c031c304b92025-08-20T03:05:10ZengNature PortfolioNature Communications2041-17232025-08-0116111610.1038/s41467-025-62738-2Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous diseaseJonas Holst Wolff0Thomas Wisbech Skov1Didde Haslund2Sofie Rahbek Dorset3Anne Louise S. Revenfeld4Clotilde Aussel5Sofie E. Jørgensen6Mette Holm7Martin K. Thomsen8Sandra Ammann9Toni Cathomen10Trine H. Mogensen11Bjarne Kuno Møller12Rasmus O. Bak13Jacob Giehm Mikkelsen14Department of Biomedicine, Aarhus UniversityDepartment of Biomedicine, Aarhus UniversityDepartment of Clinical Immunology, Aarhus University HospitalDepartment of Biomedicine, Aarhus UniversityDepartment of Clinical Immunology, Aarhus University HospitalInstitute for Transfusion Medicine and Gene Therapy, Medical Center – University of FreiburgDepartment of Infectious Diseases, Aarhus University HospitalDepartment of Paediatrics and Adolescent Medicine, Aarhus University HospitalDepartment of Biomedicine, Aarhus UniversityInstitute for Transfusion Medicine and Gene Therapy, Medical Center – University of FreiburgInstitute for Transfusion Medicine and Gene Therapy, Medical Center – University of FreiburgDepartment of Biomedicine, Aarhus UniversityDepartment of Clinical Immunology, Aarhus University HospitalDepartment of Biomedicine, Aarhus UniversityDepartment of Biomedicine, Aarhus UniversityAbstract Chronic granulomatous disease (CGD) is a severe inborn error of immunity caused by NADPH oxidase defects. Here, we develop CRISPR/Cas9-based gene editing strategies for correction of variants in the CYBA and CYBB genes causing CGD. For X-linked CGD, we also develop a near-universal gene editing strategy by targeted integration of a truncated CYBB cDNA in CD34+ hematopoietic stem and progenitor cells (HSPCs). Throughout, off-target editing and chromosomal translocations are evident, which negatively impact the ability of gene-edited HSPCs to engraft in immunodeficient mice. However, by employing a high-fidelity Cas9 to minimize off-target editing, we demonstrate restoration of the multilineage engraftment potential of gene-edited HSPCs. Moreover, to further improve safety, we develop a D10A Cas9n editing approach with no detectable off-target activity or chromosomal translocations. Collectively, through risk assessments of different gene editing approaches, we present a D10A Cas9n-based strategy with improved safety, offering a potentially curative treatment for CGD patients.https://doi.org/10.1038/s41467-025-62738-2
spellingShingle Jonas Holst Wolff
Thomas Wisbech Skov
Didde Haslund
Sofie Rahbek Dorset
Anne Louise S. Revenfeld
Clotilde Aussel
Sofie E. Jørgensen
Mette Holm
Martin K. Thomsen
Sandra Ammann
Toni Cathomen
Trine H. Mogensen
Bjarne Kuno Møller
Rasmus O. Bak
Jacob Giehm Mikkelsen
Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous disease
Nature Communications
title Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous disease
title_full Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous disease
title_fullStr Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous disease
title_full_unstemmed Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous disease
title_short Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous disease
title_sort targeted gene editing and near universal cdna insertion of cyba and cybb as a treatment for chronic granulomatous disease
url https://doi.org/10.1038/s41467-025-62738-2
work_keys_str_mv AT jonasholstwolff targetedgeneeditingandnearuniversalcdnainsertionofcybaandcybbasatreatmentforchronicgranulomatousdisease
AT thomaswisbechskov targetedgeneeditingandnearuniversalcdnainsertionofcybaandcybbasatreatmentforchronicgranulomatousdisease
AT diddehaslund targetedgeneeditingandnearuniversalcdnainsertionofcybaandcybbasatreatmentforchronicgranulomatousdisease
AT sofierahbekdorset targetedgeneeditingandnearuniversalcdnainsertionofcybaandcybbasatreatmentforchronicgranulomatousdisease
AT annelouisesrevenfeld targetedgeneeditingandnearuniversalcdnainsertionofcybaandcybbasatreatmentforchronicgranulomatousdisease
AT clotildeaussel targetedgeneeditingandnearuniversalcdnainsertionofcybaandcybbasatreatmentforchronicgranulomatousdisease
AT sofieejørgensen targetedgeneeditingandnearuniversalcdnainsertionofcybaandcybbasatreatmentforchronicgranulomatousdisease
AT metteholm targetedgeneeditingandnearuniversalcdnainsertionofcybaandcybbasatreatmentforchronicgranulomatousdisease
AT martinkthomsen targetedgeneeditingandnearuniversalcdnainsertionofcybaandcybbasatreatmentforchronicgranulomatousdisease
AT sandraammann targetedgeneeditingandnearuniversalcdnainsertionofcybaandcybbasatreatmentforchronicgranulomatousdisease
AT tonicathomen targetedgeneeditingandnearuniversalcdnainsertionofcybaandcybbasatreatmentforchronicgranulomatousdisease
AT trinehmogensen targetedgeneeditingandnearuniversalcdnainsertionofcybaandcybbasatreatmentforchronicgranulomatousdisease
AT bjarnekunomøller targetedgeneeditingandnearuniversalcdnainsertionofcybaandcybbasatreatmentforchronicgranulomatousdisease
AT rasmusobak targetedgeneeditingandnearuniversalcdnainsertionofcybaandcybbasatreatmentforchronicgranulomatousdisease
AT jacobgiehmmikkelsen targetedgeneeditingandnearuniversalcdnainsertionofcybaandcybbasatreatmentforchronicgranulomatousdisease